Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
acute disseminated encephalomyelitis
advances in neurology
adverse drug reaction
alemtuzumab
algorithm
amyloid angiopathy, cerebral
angiitis, granulomatous of CNS
angiitis, isolated of CNS
anti DNA agent
anti JC virus antibodies
antibiotics
antiviral agents
asymptomatic
ataxia
atypical
B 12 deficiency
bacterial infection
Behcet's syndrome
biologic markers
brain biopsy
brain biopsy, false negative
brain biopsy, negative
brainstem, lesion of
brentuximab
brucellosis, nervous system involvement with
Brudzinski's sign
carbon monoxide poisoning
carcinoma
CAT scan, abnormal
CAT scan, emission, abnormal
CD4 counts
central nervous system, infection of
central pontine myelinolysis
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar lesion
cerebellum, disease of
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral venous thrombosis
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, gammaglobulin of
cerebrovascular accident, secondary prevention
chemotherapy, CNS treatment and complications with
cladribine
Clinical Pathologic Conference(C.P.C.)
coinfection
Collier's sign
complications
controversies in neurology
cortical blindness
cranial neuropathy
cytosine arabinoside
daclizumab
delay in diagnosis
demyelinating disease
dermatomyositis
disability, neurological
drug abuse
drug holiday
drug induced neurologic disorders
drug withdrawal
dysarthria
efalizumab
efficacy
electroencephalogram, abnormalities of
electron microscopy
encephalitis
encephalitis, brainstem
encephalitis, human immunodeficiency virus type 1
encephalitis, paraneoplastic
encephalitis, viral
epidemiology of neurology
Epstein-Barr virus
etanercept
evidence-based research
false negative
fever
fingolimod
gadolinium
gammaglobulin therapy, intravenous
gaze palsy, vertical
gliomatosis cerebri
Guillain Barre syndrome
hearing loss
hemiparesis
hemiplegia, progressive
hepatosplenomegaly
highly active antiretroviral therapy
Hodgkin's disease
human immunodeficiency virus type 1
hydrocephalus
hypercalcemia
hypertensive encephalopathy
iatrogenic neurologic disorders
immune checkpoint inhibitors
immune reconstitution inflammatory syndrome
immune-related adverse events
immunocompetent
immunofluorescent exam of CSF cells
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
in situ hybridization
inclusion bodies
infection
infliximab
interferon
interferon beta 1-a
iododeoxyuridine
JC virus
JC virus cerebellar granule cell neuronopathy
JC virus encephalopathy
Kernig's sign
leukemia
leukemia, neurologic findings assoc.with
leukoencephalopathy
leukoencephalopathy, differential diagnosis
leukoencephalopathy, toxic
levamisole
level of consciousness, decreased
life expectancy
limbic encephalitis
listeriosis, CNS
lymph node biopsy
lymphadenopathy
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
meningismus
meningitis
midbrain
midbrain, lesion of
middle cerebellar peduncle
middle cerebellar peduncle, lesion
migraine
mitochondrial disease
monoclonal antibodies
mortality
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, diffusion weighted
MRI, magnetization transfer sequence
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRS
multiple sclerosis
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, relapsing
multiple sclerosis, treatment of
myoclonus
natalizumab
negative
neoplasm, primary of CNS
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic disease, multiple
neurologic signs
neurologic symptoms
neuromyelitis optica (Devic's disease)
neuropathology
neuropathy
neuropathy, iatrogenic
neuropathy, immune
neuropathy, medication induced
neuropathy, motor, multifocal
neuropathy, peripheral, treatment
nivolumab
ocrelizumab
Ommaya reservoir
opportunistic infection
opportunistic infection, CNS
papovavirus
pembrolizumab
phenylketonuria
plasmapheresis
plasmapheresis, complications of
pleocytosis of cerebrospinal fluid
polymerase chain reaction
polymerase chain reaction, false negative
polymyositis
polyneuropathy, chronic inflammatory demyelinating
posterior leukoencephalopathy syndrome
practice guidelines
preclinical
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psoriasis
quality of life
radiation therapy, CNS treatment and complications with
remote effect of cancer on the nervous system
review article
rheumatoid arthritis
rheumatoid arthritis, neurologic complications of
risk factors
risk stratification
risk-benefit assessment
rituximab
safety
sarcoidosis
sarcoidosis, CNS
screening
serologic testing
seropositive
slow virus infection of CNS
steroid therapy, CNS treatment and complications with
symmetric brain lesions
systemic lupus erythematosus
treatment of neurologic disorder
tuberculosis
tumor necrosis factor inhibitor
upgaze
vaccination, neurologic complications with
vaccine
vasculitides
vasculopathy
vincristine neurotoxicity
viral infection
viral infection, CNS
weakness, progressive
Whipple's disease
white matter disease
workup
Showing articles 1000 to 1050 of 3169 << Previous Next >>

Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1)
Arch Neurol 68:455-462, Kedia, S.,et al, 2011

Clinicopathologic Conference, hemophagocytic lymphohistiocytosis
NEJM 364:1259-1270, Case 10-2011, 2011

VGKC antibodies in pediatric encephalitis presenting with status epilepticus
Neurology 76:1252-1255, Suleiman, J.,et al, 2011

Increasing Incidence of Ischemic Stroke in Patients With HIV Infection
Neurol 76:444-450, Ovbiagele,B. &Nath,A., 2011

The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome
JNNP 82:671-673, Maddison, P.,et al, 2011

Use and monitoring of low dose rituximab in myasthenia gravis
JNNP 82:659-663, Blum, S., et al, 2011

CSF Complements Serum for Evaluating Paraneoplastic Antibodies and NMO-IgG
Neurol 76:1108-1110, McKeon,A.,et al, 2011

Primary Varicella Zoster Infection Associated With Fingolimod Treatment
Neurol 76:1023-1024, Uccelli,A.,et al, 2011

The Evaluation of Rapidly Progressive Dementia
The Neurologist 17:67-74, Rosenbloom,M.H. &Atri,A., 2011

GABAB Receptor Antibodies in Limbic Encephalitis and Anti-GAD-Associated Neurologic Disorders
Neurol 76:795-800, Boronat,A.,et al, 2011

Anti-Ab Autoantibodies in the CSF of a Patient With CAA-Related Inflammation: A Case Report
Neurol 76:842-844, DiFrancesco,J.C.,et al, 2011

Use of Ibuprofen and Risk of Parkinson Disease
Neurol 76:863-869, Gao,X.,et al, 2011

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma
Neurol 76:929-930, Batchelor,T.T.,et al, 2011

Fulminant Encephalopathy With Basal Ganglia Hyperintensities in HIV-Infected Drug Users
Neurol 76:787-794, Newsome,S.D.,et al, 2011

Rituximab in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Report of 13 Cases and Review of the Literature
JNNP 82:306-308, Benedetti,L.,et al, 2011

Spectrum of Paraneoplastic Disease Associated With Lymphoma
Neurol 76:705-710, Briani,C.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Current Concepts and Management of Glioblastoma
Ann Neurol 70:9-21, Preusser, M.,et al, 2011

Varicella zoster virus vasculopathy Analysis of virus-infected arteries
Neurol 77:364-370, Nagel, M.A.,et al, 2011

Tension-Type Headache
JAMA 306:450, Pluta, R.M.,et al, 2011

Fulminant Encephalopathy with Basal Ganglia Hyperintensities in HIV-infected Drug Users
Neurol 77:923, Finelli, P.F., 2011

Lumbar Puncture in Paediatric Stroke
Lancet 378:848, Neuteboom, R.F.,et al, 2011

Encephalitis Associated with Glutamic Acid Decarboxylase Autoantibodies in a Child A Treatable Condition?
Arch Neurol 68:1065-1068, Korff, C.M.,et al, 2011

Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011

N-methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-Myoclonus
Arch Neurol 68:1069-1072, Smith, J.H.,et al, 2011

Results of the Expanded HIV Testing Initiative - 25 Jurisdictions, United States 2007-2010
JAMA 306:698-700, , 2011

Paraneoplastic Upbeat Nystagmus
Neurol 77:691-693, Wray, S.H.,et al, 2011

Screening for HIV Infection A Healthy, "Low-Risk" 42-Year-Old Man
JAMA 306:637-644, Libman, H., 2011

Prevention of HIV-1 Infection with Early Antiretroviral Therapy
NEJM 365:493-505,561, Cohen, M.S.,et al, 2011

Differential Features of Carotid and Vertebral Artery Dissections
Neurol 77:1174-1181, Debette, S.,et al, 2011

Progressive Encephalomyelitis with Rigidity and Myoclonus Gycine and NMDA Receptor Antibodies
Neurol 77:439-443,414, Turner, M.R.,et al, 2011

Risk Development of Medication Overuse Headache With Nonsteroidal Anti-inflammatory Drug Therapy for Migraine A Critically Appraised Topic
The Neurologist 17:297-299, Starling, A.J.,et al, 2011

Analysis of Relapses in Anti-NMDAR Encephalitis
Neurol 77:996-999, Gabilondo, I.,et al, 2011

Narcolepsy Onset is Seasonal and Increased following the 2009 H1N1 Pandemic in China
Ann Neurol 70:410-417,A5, Han, F.,et al, 2011

Autoimmune Limbic Encephalitis with GAD Antibodies
The Neurohospitalist 1:178-181, Finelli, P.F., 2011

Routine HIV Screening - What Counts in Evidence-Based Policy?
NEJM 365:1265-1268, Bayer, R. and Oppenheimer G.M., 2011

Clinicopathologic Conference, Limbic Encephaitis with Antibodies to Leucine - Rich Glioma - inactivated 1 (LGI 1).
NEJM 365:1825-1833, Case 34-2011, 2011

Paraneoplastic and Autoimmune Encephalitis
UpToDate, June, Dalmau, J.,et al, 2011

HIV Screening of Male Inmates During Prison Intake Medical Evaluation - Washington, 2006-2010
JAMA 306:1756-1757, Strick, L.B., 2011

Teaching NeuroImages: Reversible Splenial Cytotoxic Edema in Acute Mountain Sickness
Neurol e94, Bin, C.H. and Lee, S-J., 2011

Hypereosinophilia in Patients with Multiple Sclerosis Treated with Natalizumab
Neurol 77:1561-1564, Abbas, M.,et al, 2011

Impact of Late Diagnosis and Treatment on Life Expectancy in People with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
BMJ 343:d6016,d6015, May, M.,et al, 2011

Postvaccination Miller Fisher Syndrome
Arch Neurol 68:1325-1327, Shoamanesh, A.,et al, 2011

Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes
NEJM 365:1284-1292,1338, Kimberlin, D.W.,et al, 2011

Multiple Sclerosis-Quenching the Flames of Inflammation
Lancet 378:1759-1760, , 2011

Autoimmune Encephalopathy
Semin Neurol 31:144-157, Flanagan, E.,et al, 2011

HIV Disease in the Caribbean
Top Antivir Med 19:e1-e5, Pape, J.W.,et al, 2011

Herpes Zoster Ophthalmicus and the Risk of Stroke: A Population-Based Follow-up Study
Neurol 74:792-797, 788, Lin, H.-C.,et al, 2010

Polyneuritis Cranialis Caused by Varicella Zoster Virus in the Absence of Rash
Neurol 74:85-86, Murata,K.,et al, 2010

Neurosacrcoidosis: Presentations and Management
Neurologist 16:2-15, Terushkin,V.,et al, 2010



Showing articles 1000 to 1050 of 3169 << Previous Next >>